These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34147747)

  • 1. Pyrazolotriazines: Biological activities, synthetic strategies and recent developments.
    Alizadeh SR; Ebrahimzadeh MA
    Eur J Med Chem; 2021 Nov; 223():113537. PubMed ID: 34147747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
    Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Structure and Antiproliferative Activity of New pyrazolo[4,3- e]triazolo[4,5-b][1,2,4]triazine Derivatives.
    Mojzych M; Tarasiuk P; Karczmarzyk Z; Juszczak M; Rzeski W; Fruzinski A; Wozny A
    Med Chem; 2018; 14(1):53-59. PubMed ID: 29065838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of pyrazolo[5,1-c][1,2,4]triazines as γ-aminobutyric type A (GABA
    Guerrini G; Ciciani G; Daniele S; Martini C; Costagli C; Guarino C; Selleri S
    Bioorg Med Chem; 2018 May; 26(9):2475-2487. PubMed ID: 29650463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Characterization, Antimicrobial Activity and Anticancer of Some New Pyrazolo[1,5-a]pyrimidines and Pyrazolo[5,1-c]1,2,4-triazines.
    Hosny MA; Zaki YH; Mokbel WA; Abdelhamid AO
    Med Chem; 2020; 16(6):750-760. PubMed ID: 31218963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
    Popowycz F; Schneider C; Debonis S; Skoufias DA; Kozielski F; Galmarini CM; Joseph B
    Bioorg Med Chem; 2009 May; 17(9):3471-8. PubMed ID: 19349183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of pyrazolo[4,3-
    Szymanowska A; Radomska D; Czarnomysy R; Mojzych M; Kotwica-Mojzych K; Bielawski K; Bielawska A
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2343352. PubMed ID: 38700244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR study of pyrazolo[4,3-e][1,2,4]triazine sulfonamides against tumor-associated human carbonic anhydrase isoforms IX and XII.
    Matysiak J; Skrzypek A; Tarasiuk P; Mojzych M
    Comput Biol Chem; 2017 Dec; 71():57-62. PubMed ID: 28964980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and Antimicrobial Evaluation of Some New Pyrazolo[1,5-a]pyrimidine and Pyrazolo[1,5-c]triazine Derivatives Containing Sulfathiazole Moiety.
    El-Sayed EH; Fadda AA; El-Saadaney AM
    Acta Chim Slov; 2020 Dec; 67(4):1024-1034. PubMed ID: 33533452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antitumor evaluation and microarray study of some new pyrazolo[3,4-d][1,2,3]triazine derivatives.
    Nasr T; Bondock S; Youns M; Fayad W; Zaghary W
    Eur J Med Chem; 2017 Dec; 141():603-614. PubMed ID: 29107422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New pyrazolo[4,3-e][1,2,4]triazine sulfonamides as carbonic anhydrase inhibitors.
    Mojzych M; Ceruso M; Bielawska A; Bielawski K; Fornal E; Supuran CT
    Bioorg Med Chem; 2015 Jul; 23(13):3674-80. PubMed ID: 25921266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of pyrazolo[4,3-e][1,2,4]triazine sulfonamides, novel Sildenafil analogs with tyrosinase inhibitory activity.
    Mojzych M; Dolashki A; Voelter W
    Bioorg Med Chem; 2014 Dec; 22(23):6616-6624. PubMed ID: 25456386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.
    Sun L; Bera H; Chui WK
    Eur J Med Chem; 2013 Jul; 65():1-11. PubMed ID: 23688695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, antibacterial activity and cytotoxicity of new fused pyrazolo[1,5-a]pyrimidine and pyrazolo[5,1-c][1,2,4]triazine derivatives from new 5-aminopyrazoles.
    Al-Adiwish WM; Tahir MI; Siti-Noor-Adnalizawati A; Hashim SF; Ibrahim N; Yaacob WA
    Eur J Med Chem; 2013 Jun; 64():464-76. PubMed ID: 23669354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of Novel [1,2,4]Triazolo[5,1-c][1,2,4]-triazines and Pyrazolo[5,1-c][1,2,4]triazines as Potential Antidiabetic Agents.
    Rusinov VL; Sapozhnikova IM; Bliznik AM; Chupakhin ON; Charushin VN; Spasov AA; Vassiliev PM; Kuznetsova VA; Rashchenko AI; Babkov DA
    Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28393419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II.
    Bera H; Ojha Pk; Tan BJ; Sun L; Dolzhenko AV; Chui WK; Chiu GN
    Eur J Med Chem; 2014 May; 78():294-303. PubMed ID: 24686016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazoloquinazolines: Synthetic strategies and bioactivities.
    Garg M; Chauhan M; Singh PK; Alex JM; Kumar R
    Eur J Med Chem; 2015 Jun; 97():444-61. PubMed ID: 25438709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and enzymic activity of various substituted pyrazolo[1,5-a]-1,3,5-triazines as adenosine cyclic 3',5'-phosphate phosphodiesterase inhibitors.
    Senga K; O'Brien DE; Scholten MB; Novinson T; Miller JP; Robins RK
    J Med Chem; 1982 Mar; 25(3):243-9. PubMed ID: 6279842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist.
    He L; Gilligan PJ; Zaczek R; Fitzgerald LW; McElroy J; Shen HS; Saye JA; Kalin NH; Shelton S; Christ D; Trainor G; Hartig P
    J Med Chem; 2000 Feb; 43(3):449-56. PubMed ID: 10669572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.